Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$24.72
+1.6%
$25.09
$16.63
$26.16
$16.79B1.364.98 million shs3.44 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$279.83
+0.2%
$318.52
$261.59
$468.45
$7.98B0.94222,366 shs196,160 shs
Revvity, Inc. stock logo
RVTY
Revvity
$100.61
-0.5%
$104.56
$79.50
$132.54
$12.43B1.091.02 million shs859,139 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
-0.02%+3.26%-1.51%+5.55%+22.38%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.00%+1.41%-13.45%-12.67%-39.67%
Revvity, Inc. stock logo
RVTY
Revvity
0.00%-0.89%-1.05%-4.74%+10,060,999,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avantor, Inc. stock logo
AVTR
Avantor
4.6114 of 5 stars
2.44.00.03.23.22.53.1
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6187 of 5 stars
3.43.00.04.21.93.31.9
Revvity, Inc. stock logo
RVTY
Revvity
3.3009 of 5 stars
2.32.01.70.03.82.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
2.75
Moderate Buy$26.718.07% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0067.24% Upside
Revvity, Inc. stock logo
RVTY
Revvity
2.54
Moderate Buy$118.1717.45% Upside

Current Analyst Ratings

Latest RVTY, AVTR, and BIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/30/2024
Revvity, Inc. stock logo
RVTY
Revvity
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$126.00 ➝ $127.00
4/30/2024
Revvity, Inc. stock logo
RVTY
Revvity
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$123.00 ➝ $130.00
4/29/2024
Avantor, Inc. stock logo
AVTR
Avantor
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$27.00 ➝ $26.00
4/18/2024
Avantor, Inc. stock logo
AVTR
Avantor
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$23.00 ➝ $25.00
4/10/2024
Avantor, Inc. stock logo
AVTR
Avantor
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$27.00 ➝ $30.00
4/4/2024
Avantor, Inc. stock logo
AVTR
Avantor
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$26.00 ➝ $28.00
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$484.00 ➝ $480.00
2/15/2024
Avantor, Inc. stock logo
AVTR
Avantor
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$25.00 ➝ $29.00
2/15/2024
Avantor, Inc. stock logo
AVTR
Avantor
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$24.00 ➝ $30.00
(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.97B2.41$1.68 per share14.73$7.86 per share3.15
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B2.99$12.11 per share23.11$306.51 per share0.91
Revvity, Inc. stock logo
RVTY
Revvity
$2.75B4.52$8.26 per share12.18$63.52 per share1.58

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
$321.10M$0.3963.3819.941.503.79%13.01%5.22%7/26/2024 (Estimated)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.42N/A-23.86%3.90%2.77%5/7/2024 (Confirmed)
Revvity, Inc. stock logo
RVTY
Revvity
$693.09M$1.2183.1519.392.625.49%7.37%4.22%8/6/2024 (Estimated)

Latest RVTY, AVTR, and BIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.04N/A-$2.04N/AN/AN/A  
4/29/2024Q1 24
Revvity, Inc. stock logo
RVTY
Revvity
$0.94$0.98+$0.04$1.75$646.83 million$649.90 million    
4/26/2024Q1 2024
Avantor, Inc. stock logo
AVTR
Avantor
$0.20$0.22+$0.02$0.35$1.68 billion$1.68 billion      
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      
2/14/202412/31/2023
Avantor, Inc. stock logo
AVTR
Avantor
$0.22$0.25+$0.03$0.35$1.70 billion$1.72 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Revvity, Inc. stock logo
RVTY
Revvity
$0.280.28%N/A23.14%N/A

Latest RVTY, AVTR, and BIO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2024
Revvity, Inc. stock logo
RVTY
Revvity
quarterly$0.070.27%7/19/20247/19/20248/9/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
0.94
1.61
1.05
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34
Revvity, Inc. stock logo
RVTY
Revvity
0.40
2.23
1.77

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Revvity, Inc. stock logo
RVTY
Revvity
86.65%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
1.50%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.06%
Revvity, Inc. stock logo
RVTY
Revvity
0.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
14,500679.27 million669.08 millionOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.65 millionOptionable
Revvity, Inc. stock logo
RVTY
Revvity
11,500123.53 million122.78 millionOptionable

RVTY, AVTR, and BIO Headlines

SourceHeadline
Truist Financial Corp Makes New Investment in Revvity, Inc. (NYSE:RVTY)Truist Financial Corp Makes New Investment in Revvity, Inc. (NYSE:RVTY)
marketbeat.com - May 4 at 5:37 AM
Yousif Capital Management LLC Takes Position in Revvity, Inc. (NYSE:RVTY)Yousif Capital Management LLC Takes Position in Revvity, Inc. (NYSE:RVTY)
marketbeat.com - May 3 at 5:15 AM
8,200 Shares in Revvity, Inc. (NYSE:RVTY) Purchased by Levin Capital Strategies L.P.8,200 Shares in Revvity, Inc. (NYSE:RVTY) Purchased by Levin Capital Strategies L.P.
marketbeat.com - May 2 at 3:40 PM
Comparing Avantor (NYSE:AVTR) & Revvity (NYSE:RVTY)Comparing Avantor (NYSE:AVTR) & Revvity (NYSE:RVTY)
americanbankingnews.com - May 2 at 1:10 AM
Searle & CO. Purchases New Stake in Revvity, Inc. (NYSE:RVTY)Searle & CO. Purchases New Stake in Revvity, Inc. (NYSE:RVTY)
marketbeat.com - May 1 at 5:24 PM
Revvity (NYSE:RVTY) Price Target Raised to $127.00 at Robert W. BairdRevvity (NYSE:RVTY) Price Target Raised to $127.00 at Robert W. Baird
americanbankingnews.com - May 1 at 5:38 AM
Revvity (NYSE:RVTY) Given New $130.00 Price Target at TD CowenRevvity (NYSE:RVTY) Given New $130.00 Price Target at TD Cowen
americanbankingnews.com - May 1 at 4:26 AM
4 Analysts Have This To Say About Revvity4 Analysts Have This To Say About Revvity
markets.businessinsider.com - April 30 at 1:41 PM
Revvity (NYSE:RVTY) Price Target Increased to $127.00 by Analysts at Robert W. BairdRevvity (NYSE:RVTY) Price Target Increased to $127.00 by Analysts at Robert W. Baird
marketbeat.com - April 30 at 12:29 PM
Revvity Inc (RVTY) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...Revvity Inc (RVTY) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
finance.yahoo.com - April 30 at 8:41 AM
Revvity Inc (RVTY) Q1 Earnings: Adjusted EPS Beats Estimates, Revenue DeclinesRevvity Inc (RVTY) Q1 Earnings: Adjusted EPS Beats Estimates, Revenue Declines
finance.yahoo.com - April 29 at 2:18 PM
Revvity (RVTY) Q1 Earnings and Revenues Surpass EstimatesRevvity (RVTY) Q1 Earnings and Revenues Surpass Estimates
zacks.com - April 29 at 1:16 PM
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024
investorplace.com - April 29 at 12:06 PM
Revvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to SayRevvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to Say
zacks.com - April 29 at 10:30 AM
Revvity: Q1 Earnings SnapshotRevvity: Q1 Earnings Snapshot
chron.com - April 29 at 9:18 AM
Revvity beats top-line and bottom-line estimates; updates FY24 outlookRevvity beats top-line and bottom-line estimates; updates FY24 outlook
msn.com - April 29 at 9:18 AM
Revvity, Inc. Q1 Profit Decreases, but beats estimatesRevvity, Inc. Q1 Profit Decreases, but beats estimates
markets.businessinsider.com - April 29 at 9:18 AM
Revvity (NYSE:RVTY) Announces Quarterly  Earnings ResultsRevvity (NYSE:RVTY) Announces Quarterly Earnings Results
marketbeat.com - April 29 at 8:32 AM
Revvity (NYSE:RVTY) Issues FY24 Earnings GuidanceRevvity (NYSE:RVTY) Issues FY24 Earnings Guidance
marketbeat.com - April 29 at 8:32 AM
Revvity (RVTY) Beats Q1 Earnings and Revenue EstimatesRevvity (RVTY) Beats Q1 Earnings and Revenue Estimates
zacks.com - April 29 at 8:11 AM
Revvity beats quarterly estimates on demand for diagnostic equipmentRevvity beats quarterly estimates on demand for diagnostic equipment
reuters.com - April 29 at 7:42 AM
Revvity Announces Financial Results for the First Quarter of 2024Revvity Announces Financial Results for the First Quarter of 2024
businesswire.com - April 29 at 6:00 AM
Revvity, Inc. (NYSE:RVTY) Short Interest UpdateRevvity, Inc. (NYSE:RVTY) Short Interest Update
marketbeat.com - April 28 at 7:31 AM
Illinois Municipal Retirement Fund Takes Position in Revvity, Inc. (NYSE:RVTY)Illinois Municipal Retirement Fund Takes Position in Revvity, Inc. (NYSE:RVTY)
marketbeat.com - April 28 at 6:17 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Avantor logo

Avantor

NYSE:AVTR
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Revvity logo

Revvity

NYSE:RVTY
Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.